# OnCo record checkpoint-inhibitor-baseline-and-monitoring (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/checkpoint-inhibitor-baseline-and-monitoring/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "checkpoint-inhibitor-baseline-and-monitoring" ;
  schema:name "Baseline tests and monitoring before and during checkpoint inhibitor treatment"@en ;
  schema:alternateName "baseline tests before immunotherapy"@en, "ICI pre-treatment screening"@en, "checkpoint inhibitor monitoring bloods"@en, "thyroid and cortisol monitoring on immunotherapy"@en, "pre-immunotherapy checklist"@en ;
  schema:description "Before immunotherapy such as pembrolizumab or nivolumab starts, your team checks your blood count, kidney and liver tests, thyroid and often cortisol and sugar levels, and asks about autoimmune and lung conditions. Some tests are repeated before each dose, because immunotherapy side effects are often found on a blood test before you feel them."@en ;
  schema:url <https://onco.cc/protocols/checkpoint-inhibitor-baseline-and-monitoring/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "irae" ;
  onco:related <https://onco.cc/protocols/irae-hypophysitis-adrenal/>, <https://onco.cc/protocols/irae-hepatitis/>, <https://onco.cc/protocols/irae-pneumonitis/>, <https://onco.cc/protocols/irae-colitis/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cardiac-biomarker-monitoring/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/drugs/tremelimumab/>, <https://onco.cc/drugs/avelumab/> ;
  onco:institutions <https://onco.cc/institutions/sitc/>, <https://onco.cc/institutions/esmo/> ;
  onco:terms <https://onco.cc/terms/irae/>, <https://onco.cc/terms/immune-endocrinopathy/>, <https://onco.cc/terms/myocarditis/> .